ImportRefusal LogoImportRefusal

BC LTD C/O PASTURE

🚨 Critical Risk

FEI: 3039097162 β€’ Singapore β€’ SINGAPORE

FEI

FEI Number

3039097162

πŸ“

Location

Singapore

πŸ‡ΈπŸ‡¬

Country

SINGAPORE
🏒

Address

2 Corporation Road, Corporation Place; Floor 03 Unit 04 05, Singapore, , Singapore

Critical Risk

FDA Import Risk Assessment

75.8
LowModerateHighCritical

This firm has an extensive history of FDA import refusals with severe violations.

Statistics

65
Total Refusals
4
Unique Violations
1/22/2026
Latest Refusal
8/6/2025
Earliest Refusal

Score Breakdown

Violation Severity
65.0Γ—40%
Refusal Volume
67.4Γ—30%
Recency
97.8Γ—20%
Frequency
100.0Γ—10%
How is this score calculated?

Proprietary Algorithm

  • 40% Violation Severity β€” AI-assessed (1-10)
  • 30% Refusal Volume β€” Logarithmic scale
  • 20% Recency β€” Decays over 5 years
  • 10% Frequency β€” Refusals per year

Β© ImportRefusal.com Original Analysis

Violation Summary

7536Γ—

UNAPPROVED

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).

11834Γ—

NOT LISTED

It appears the drug or device is not included in a list required by Section 510(j), or a notice or other information respecting it was not provided as required by section 510(j) or 510(k).

328028Γ—

FRNMFGREG

The article is subject to refusal of admission pursuant to section 801(a)(3) in that it appears to be misbranded as defined in section 502(o) of the FD&C Act. It appears that it was manufactured, prepared, propagated, compounded, or processed in an establishment not duly registered under section 510 of the Act.

722Γ—

NEW VET DR

The article is subject to refusal of admission pursuant to Section 801(a)(3) of the Federal Food, Drug, and Cosmetic Act in that it appears to be a new animal drug that is unsafe within the meaning of Section 512(a) of the Federal Food, Drug, and Cosmetic Act as it is not the subject of an approved new animal drug application, conditionally approved new animal drug application, or index listing, and no investigational new animal drug exemption applies.

Refusal History

DateProductViolationsDivision
1/22/2026
66VCY99MISCELLANEOUS PATENT MEDICINES, ETC.
75UNAPPROVED
Division of Southeast Imports (DSEI)
1/21/2026
60CCY61MIRABEGRON (ADRENERGIC)
75UNAPPROVED
Division of Southeast Imports (DSEI)
11/19/2025
61PCA70DAPAGLIFLOZIN (ANTI-DIABETIC)
118NOT LISTED
3280FRNMFGREG
Division of West Coast Imports (DWCI)
11/12/2025
61FCY63RIFAXIMIN (A-BACTERIAL PT. I) (NOT ANTIBIOTIC)
118NOT LISTED
3280FRNMFGREG
Division of West Coast Imports (DWCI)
11/10/2025
61FCA63RIFAXIMIN (A-BACTERIAL PT. I) (NOT ANTIBIOTIC)
75UNAPPROVED
Division of Southeast Imports (DSEI)
10/31/2025
61LAY42RIVAROXABAN
75UNAPPROVED
Division of Southeast Imports (DSEI)
10/28/2025
61LCY44APIXABAN (ANTI-COAGULANT)
118NOT LISTED
3280FRNMFGREG
Division of West Coast Imports (DWCI)
10/28/2025
61PCA73EMPAGLIFLOZIN (ANTI-DIABETIC)
118NOT LISTED
3280FRNMFGREG
Division of West Coast Imports (DWCI)
10/28/2025
61LCY44APIXABAN (ANTI-COAGULANT)
118NOT LISTED
3280FRNMFGREG
Division of West Coast Imports (DWCI)
10/28/2025
61PCY73EMPAGLIFLOZIN (ANTI-DIABETIC)
118NOT LISTED
3280FRNMFGREG
Division of West Coast Imports (DWCI)
10/28/2025
66VCY99MISCELLANEOUS PATENT MEDICINES, ETC.
118NOT LISTED
3280FRNMFGREG
Division of West Coast Imports (DWCI)
10/28/2025
61FCA63RIFAXIMIN (A-BACTERIAL PT. I) (NOT ANTIBIOTIC)
118NOT LISTED
3280FRNMFGREG
Division of West Coast Imports (DWCI)
10/21/2025
60CCA61MIRABEGRON (ADRENERGIC)
118NOT LISTED
75UNAPPROVED
Division of Southeast Imports (DSEI)
10/19/2025
61LAY42RIVAROXABAN
75UNAPPROVED
Division of Southeast Imports (DSEI)
10/16/2025
61LAY42RIVAROXABAN
118NOT LISTED
3280FRNMFGREG
Division of West Coast Imports (DWCI)
10/14/2025
61LDY44APIXABAN (ANTI-COAGULANT)
118NOT LISTED
3280FRNMFGREG
Division of West Coast Imports (DWCI)
10/14/2025
61LDY44APIXABAN (ANTI-COAGULANT)
118NOT LISTED
3280FRNMFGREG
Division of West Coast Imports (DWCI)
10/14/2025
61PDY73EMPAGLIFLOZIN (ANTI-DIABETIC)
118NOT LISTED
3280FRNMFGREG
Division of West Coast Imports (DWCI)
10/9/2025
62TDY02LANSOPRAZOLE (ANTI-SECRETORY)
118NOT LISTED
3280FRNMFGREG
Division of West Coast Imports (DWCI)
10/7/2025
61LCY44APIXABAN (ANTI-COAGULANT)
75UNAPPROVED
Division of Southeast Imports (DSEI)
10/7/2025
61LCY44APIXABAN (ANTI-COAGULANT)
75UNAPPROVED
Division of Southeast Imports (DSEI)
10/7/2025
61LCY44APIXABAN (ANTI-COAGULANT)
75UNAPPROVED
Division of Southeast Imports (DSEI)
10/7/2025
61JCY13PRAVASTATIN SODIUM (ANTI-CHOLESTEREMIC)
75UNAPPROVED
Division of Southeast Imports (DSEI)
10/6/2025
61LDY44APIXABAN (ANTI-COAGULANT)
118NOT LISTED
3280FRNMFGREG
Division of West Coast Imports (DWCI)
10/6/2025
61LDY44APIXABAN (ANTI-COAGULANT)
118NOT LISTED
3280FRNMFGREG
Division of West Coast Imports (DWCI)
10/6/2025
61LCY44APIXABAN (ANTI-COAGULANT)
75UNAPPROVED
Division of Southeast Imports (DSEI)
10/6/2025
61LCA44APIXABAN (ANTI-COAGULANT)
118NOT LISTED
3280FRNMFGREG
Division of West Coast Imports (DWCI)
10/6/2025
61LCA44APIXABAN (ANTI-COAGULANT)
118NOT LISTED
3280FRNMFGREG
Division of West Coast Imports (DWCI)
9/29/2025
61PCY70DAPAGLIFLOZIN (ANTI-DIABETIC)
118NOT LISTED
75UNAPPROVED
Division of Southeast Imports (DSEI)
9/29/2025
60ZAH01AFOXOLANER (ANTIPARASITIC)
118NOT LISTED
72NEW VET DR
Division of Southeast Imports (DSEI)
9/29/2025
61PCY73EMPAGLIFLOZIN (ANTI-DIABETIC)
118NOT LISTED
75UNAPPROVED
Division of Southeast Imports (DSEI)
9/29/2025
61LCY44APIXABAN (ANTI-COAGULANT)
118NOT LISTED
75UNAPPROVED
Division of Southeast Imports (DSEI)
9/26/2025
60ZQL35SELAMECTIN (ANTIPARASITIC)
75UNAPPROVED
Division of Southeast Imports (DSEI)
9/26/2025
60ZQY01AFOXOLANER (ANTIPARASITIC)
72NEW VET DR
Division of Southeast Imports (DSEI)
9/24/2025
61PCA72SEMAGLUTIDE (ANTI-DIABETIC)
118NOT LISTED
3280FRNMFGREG
75UNAPPROVED
Division of Southeast Imports (DSEI)
9/24/2025
61LDY42RIVAROXABAN
118NOT LISTED
3280FRNMFGREG
Division of West Coast Imports (DWCI)
9/24/2025
61LCA44APIXABAN (ANTI-COAGULANT)
118NOT LISTED
3280FRNMFGREG
Division of West Coast Imports (DWCI)
9/24/2025
61PCA70DAPAGLIFLOZIN (ANTI-DIABETIC)
75UNAPPROVED
Division of Southeast Imports (DSEI)
9/23/2025
61LCY44APIXABAN (ANTI-COAGULANT)
75UNAPPROVED
Division of Southeast Imports (DSEI)
9/23/2025
61LCY44APIXABAN (ANTI-COAGULANT)
75UNAPPROVED
Division of Southeast Imports (DSEI)
9/23/2025
61LCY44APIXABAN (ANTI-COAGULANT)
75UNAPPROVED
Division of Southeast Imports (DSEI)
9/23/2025
61LCY44APIXABAN (ANTI-COAGULANT)
75UNAPPROVED
Division of Southeast Imports (DSEI)
9/19/2025
66VDQ99MISCELLANEOUS PATENT MEDICINES, ETC.
75UNAPPROVED
Division of Southeast Imports (DSEI)
9/17/2025
61LCA44APIXABAN (ANTI-COAGULANT)
75UNAPPROVED
Division of Southeast Imports (DSEI)
9/17/2025
61FCY63RIFAXIMIN (A-BACTERIAL PT. I) (NOT ANTIBIOTIC)
118NOT LISTED
75UNAPPROVED
Division of Southeast Imports (DSEI)
9/15/2025
61FBB63RIFAXIMIN (A-BACTERIAL PT. I) (NOT ANTIBIOTIC)
75UNAPPROVED
Division of Southeast Imports (DSEI)
9/15/2025
61LCA44APIXABAN (ANTI-COAGULANT)
118NOT LISTED
3280FRNMFGREG
Division of West Coast Imports (DWCI)
9/15/2025
61PCA73EMPAGLIFLOZIN (ANTI-DIABETIC)
118NOT LISTED
3280FRNMFGREG
Division of West Coast Imports (DWCI)
9/11/2025
61LCA44APIXABAN (ANTI-COAGULANT)
75UNAPPROVED
Division of Southeast Imports (DSEI)
9/11/2025
61PDY70DAPAGLIFLOZIN (ANTI-DIABETIC)
75UNAPPROVED
Division of Southeast Imports (DSEI)
9/11/2025
61PCA73EMPAGLIFLOZIN (ANTI-DIABETIC)
75UNAPPROVED
Division of Southeast Imports (DSEI)
9/11/2025
61LCA44APIXABAN (ANTI-COAGULANT)
75UNAPPROVED
Division of Southeast Imports (DSEI)
9/10/2025
60CCY61MIRABEGRON (ADRENERGIC)
75UNAPPROVED
Division of Southeast Imports (DSEI)
9/10/2025
62GCY89CYCLOSPORINE (ANTI-INFLAMMATORY)
118NOT LISTED
3280FRNMFGREG
Division of West Coast Imports (DWCI)
9/9/2025
61PCY73EMPAGLIFLOZIN (ANTI-DIABETIC)
118NOT LISTED
3280FRNMFGREG
Division of West Coast Imports (DWCI)
9/9/2025
61LDB44APIXABAN (ANTI-COAGULANT)
75UNAPPROVED
Division of Southeast Imports (DSEI)
9/9/2025
61PCA73EMPAGLIFLOZIN (ANTI-DIABETIC)
118NOT LISTED
3280FRNMFGREG
Division of West Coast Imports (DWCI)
9/9/2025
61LCY44APIXABAN (ANTI-COAGULANT)
118NOT LISTED
3280FRNMFGREG
Division of West Coast Imports (DWCI)
9/8/2025
60CCY61MIRABEGRON (ADRENERGIC)
118NOT LISTED
3280FRNMFGREG
Division of West Coast Imports (DWCI)
9/8/2025
61LCY44APIXABAN (ANTI-COAGULANT)
118NOT LISTED
3280FRNMFGREG
Division of West Coast Imports (DWCI)
9/5/2025
61LCY44APIXABAN (ANTI-COAGULANT)
75UNAPPROVED
Division of Southeast Imports (DSEI)
9/4/2025
61LCY44APIXABAN (ANTI-COAGULANT)
75UNAPPROVED
Division of Southeast Imports (DSEI)
8/19/2025
61PCY70DAPAGLIFLOZIN (ANTI-DIABETIC)
75UNAPPROVED
Division of Southeast Imports (DSEI)
8/12/2025
61LCY44APIXABAN (ANTI-COAGULANT)
75UNAPPROVED
Division of Southeast Imports (DSEI)
8/6/2025
61PCY72SEMAGLUTIDE (ANTI-DIABETIC)
75UNAPPROVED
Division of Southeast Imports (DSEI)

Frequently Asked Questions

What is BC LTD C/O PASTURE's FDA import refusal history?

BC LTD C/O PASTURE (FEI: 3039097162) has 65 FDA import refusal record(s) in our database, spanning from 8/6/2025 to 1/22/2026.

What is an FEI number?

FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. BC LTD C/O PASTURE's FEI number is 3039097162.

What types of violations has BC LTD C/O PASTURE received?

BC LTD C/O PASTURE has been cited for 4 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.

Where does this information about BC LTD C/O PASTURE come from?

All FDA import refusal data for BC LTD C/O PASTURE is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.